Ledger.Open graph →
SEC Form D · Amendment · filed January 4, 2013

Altheus Therapeutics Inc

Offering
$5.9M
Sold
$5.9M
Exemption
—
Industry
Biotechnology
Location
OKLAHOMA CITY, OK
Type
—

People & firms on this filing (7)

Deborah A. Farrington · NEW YORK, NYExec · PromoterJohn W. Sinnenberg · CLEVELAND, OHDirectorPhilip S. Curatilo · CLEVELAND, OHExec · DirectorTed R. Laufik · CLEVELAND, OHDirectorW. P. Rond · CLEVELAND, OHDirectorDaniel J. Kessler · CLEVELAND, OHExecBeth H. Laschinger · CLEVELAND, OHDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗